Aaron Sanchez – Página 144

First-Of-Its-Kind Report Details How New York Children’s Hospital Transformed To Provide Care To Adult COVID-19 Patients

NEW YORK, May 4, 2020 /PRNewswire-HISPANIC PR WIRE/ — Over the course of two weeks in March, COVID-19 cases at Montefiore grew from two to almost 700. As the health system looked to increase capacity, an inpatient pediatric unit at the Children’s Hospital at Montefiore (CHAM), quickly became a 40-bed unit that would be home to adult patients. A new, first-of-its-kind report published in the Journal of Pediatrics describes the rapid transformation that took place. The report also shares valuable lessons learned and best practices for healthcare providers throughout the country, who may face a similar situation in the weeks ahead.

«In collaboration with our adult care providers, we quickly trained CHAM clinicians on how to provide an effective, informed and thoughtful approach to care for our new adult patients,» said lead author Kaitlyn Philips, DO, assistant medical director of Pediatric Quality, CHAM, and assistant professor of pediatrics, Albert Einstein College of Medicine. «In a matter of weeks, our physicians and nurses became accustomed to new policies and protocols, caring for adults with a highly contagious disease, and many with other underlying conditions.»

Instead of assigning pediatricians to be part of teams led by adult medicine physicians, Montefiore developed a strategy of training pediatrician-led teams and having them work within their own familiar setting. Established CHAM teams of pediatric physicians and nurses consulted with adult-medicine physicians to provide life-saving care to more than 100 patients within 10 days of accepting adults. The new report outlines the steps taken to prepare and train pediatric healthcare providers on how to treat a new, older population, including enhanced communication, adapted rounding practices, and a new coordinated approach with adult hospital medicine providers.

«This effort is a true example of interdisciplinary care and all-hands-on-deck preparation,» said Michael D. Cabana, M.D., MPH, Physician-in-Chief at CHAM and The Michael I. Cohen, M.D., University Chair, Department of Pediatrics at Albert Einstein College of Medicine. «Our teams mobilized early, quickly and effectively to provide high-quality care to the parents and grandparents of their usual patients. Being part of a large, integrated healthcare system enabled us to access the expertise and resources necessary to provide this care.»

In addition to providing recommended therapies for adults, the team recognized that palliative care would be essential. Dr. Cabana and Dr. Sarah Norris, director of Pediatric Palliative Care and the Quality in Life Team (QUILT) at CHAM gathered and trained 27 pediatricians, nurse practitioners and psychologists in just one week. They were then deployed throughout the adult COVID-19 unit at CHAM to help patients and their families stay connected, informed and educated during hospitalization. The expanded QUILT team became a lifeline for patients and their families, available seven days per week to help them as they faced complex medical decisions and uncertainty.

The last adult patient has been discharged from CHAM 8 and the providers will now care for pediatric patients again. Approximately 150 adults received COVID-19 treatment at CHAM.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

Mazda Extends Essential Car Care Program For Healthcare Heroes

IRVINE, California, May 4, 2020 /PRNewswire-HISPANIC PR WIRE/ — Mazda North American Operations (MNAO) announced today that its Essential Car Care program, which provides free standard oil changes and enhanced car cleaning services for eligible U.S. healthcare workers at dealers nationwide, will now run through June 1.

<img id="prnejpgd450left" title="Mazda extends Essential Car Care…

Mazda extends Essential Car Care program for healthcare heroes

«Our family of Mazda dealers and employees feel a deep sense of gratitude to the health care workers during these difficult times, and we are proud to be able to support them in communities across the country,» MNAO President Jeff Guyton said. «We’ve seen the meaningful impact of this program first-hand, and we are excited to continue to give something back as a thank you for their heroic efforts.»

The Essential Car Care program, which began on April 16, was developed in partnership with Mazda’s U.S. dealer network. The company will invest a minimum of $5 million as part of the initiative. The program extension will allow healthcare heroes throughout the U.S., including those in some of the hardest hit parts of the country, more time to access this program.

In order to help ensure the safety of healthcare workers and service employees, dealers participating in the Essential Car Care initiative have committed to enhanced vehicle cleaning of high-touch interior and exterior surfaces using Mazda and EPA-approved cleansers. Mazda has also encouraged dealers to continue following the recommendations from the CDC and local public health and government officials, along with workplace personal hygiene practices to help ensure the safety of everyone in the service areas.

Details on the Essential Car Care initiative can be found on MazdaUSA.com.

Mazda North American Operations is headquartered in Irvine, California, and oversees the sales, marketing, parts and customer service support of Mazda vehicles in the United States and Mexico through approximately 620 dealers. For more information on Mazda vehicles, including photography and B-roll, please visit the online Mazda media center at InsideMazda.MazdaUSA.com/Newsroom.

Follow MNAO’s social media channels through Twitter and Instagram at @MazdaUSA and Facebook at Facebook.com/MazdaUSA.

Photo – https://mma.prnewswire.com/media/1163383/Mazda_Service.jpg
Logo – https://mma.prnewswire.com/media/53154/mazda_north_american_operations_logo.jpg

SOURCE Mazda North American Operations

Makita Rules the Outdoors with the World’s Largest Professional Cordless Outdoor Power Equipment System

LA MIRADA, California, May 4, 2020 /PRNewswire-HISPANIC PR WIRE/ — Makita U.S.A., Inc., the innovation leader in cordless technology, is continuing to make significant investments in designing cordless outdoor power equipment and driving awareness with a national multi-media campaign. The «Rule the Outdoors» campaign highlights the world’s largest professional cordless outdoor power equipment system, which benefits users with instant starts, lower noise, reduced…

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8722351-makita-cordless-power-equipment-rule-the-outdoors/

The Future of Cordless Outdoor Power Equipment is Now

With advances in technology and increasing government regulations, professional landscapers, groundskeepers, and arborists are looking to battery-operated outdoor power equipment as a new solution.

«The industry growth of cordless products has immensely accelerated,» said Romique Talton, senior product manager, outdoor power equipment, Makita U.S.A. «Makita has the world’s largest professional cordless outdoor power equipment system. And with millions of LXT Batteries already in the market, Makita is uniquely positioned to capitalize on this growth opportunity. With the recent launch of Makita’s new 21″ commercial lawn mowers, users can cut up to 2 miles of grass in push mode, get high-torque performance, and have lower cost of ownership than gas models.»

Makita offers the world’s largest professional cordless outdoor power equipment system with over 30 professional pieces of equipment operating on Makita’s LXT^® lithium-ion slide-style battery. By utilizing one extensive system, users experience new levels of convenience, efficiency, and productivity.

Makita^® LXT^® Cordless Outdoor Power Equipment

Makita’s battery-powered outdoor power equipment is engineered for maximum cordless performance, without the hassles of gas. The «Rule the Outdoors» campaign promotes Makita^® LXT Cordless Outdoor Power Equipment, which is powered by a fast-charging LXT lithium-ion battery and Makita-built motors, which work together to provide more power, speed, and run-time. Benefits of battery-powered outdoor power equipment include instant starts, lower noise, reduced maintenance, and zero emissions.

«No one knows cordless like us,» asserts Talton. «We have over 90 years of chain saw and gas expertise and over 40 years of cordless expertise. This knowledge and experience have been invested into product development and has resulted in the largest offering of cordless outdoor power equipment on the market.»

For more information, visit makitatools.com/RTO

Multi-Media Campaign

With the success of last year’s launch of the «Rule the Outdoors» campaign, Makita is extending the campaign with new television commercials, digital and social media advertising, and experiential marketing efforts. Television commercials will run nationally during prime-time spots on channels such as the Discovery Channel, History Channel, ESPN, National Geographic and more generating another 300-million household impressions. The national media campaign will build product awareness and demand from the professional outdoor power equipment user, professional tool user, and professional who uses both at work and home.

«The overall success of the campaign last year exceeded everyone’s expectations,» states Brent Withey, vice president of brand marketing, Makita U.S.A., Inc. «We want to continue that success by promoting Makita’s wide range of cordless outdoor power equipment across a variety of media.»

The television commercials can also be viewed at www.youtube.com/makitatools

About the Makita^® 18V LXT^® System

Makita’s expanding 18V LXT System is the world’s largest cordless tool system powered by 18V lithium-ion slide-style batteries, comprising 275+ products in 2021. Makita 18V LXT Lithium-Ion Batteries have the fastest charge times in their categories, so they spend more time working and less time sitting on the charger.

About Makita

Makita is a worldwide manufacturer of industrial power tools, pneumatics and power equipment, and offers a wide range of industrial accessories. Makita U.S.A., Inc. is located in La Mirada, California, and operates an extensive distribution network throughout the U.S.A. With 50 years in the United States and over 100 years worldwide, Makita utilizes experience and expertise to manufacture best-in-class solutions. For more information call Makita U.S.A. at (800)4-MAKITA or visit makitatools.com. Find Makita on Instagram, YouTube, Facebook, and Twitter @makitatools

MEDIA CONTACTS
Wayne Hart
(714) 522-8088 x4410
whart@makitausa.com

Jennifer Morse
(714) 522-8088 x 4401
jmorse@makitausa.com

Consumer Inquiries:
(800) 4-MAKITA
makitatools.com
@makitatools

SOURCE Makita U.S.A.

American Honda Reports April Auto Sales as Difficult Market Conditions Begin to Ease

TORRANCE, Calif., May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ —

<table cellspacing="0" cellpadding="0" border="1"…

TORRANCE, Calif., May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ —

American Honda			Honda			Acura
Total	Cars	Trucks	Total	Cars	Trucks	Total	Cars	Trucks
57,751	25,610	32,141	52,705	24,049	28,656	5,046	1,561	3,485
-54.1%	-55.4%	-53.0%	-53.8%	-55.5%	-52.3%	-56.8%	-54.4%	-57.8%

«There will be challenging days ahead as this very serious public health crisis continues, but with consumer traffic beginning to increase online and at Honda and Acura dealerships, we are approaching the coming weeks with guarded optimism,» said Steven Center, vice president of Automobile Sales at American Honda Motor Co., Inc. «We value the actions of our Honda associates and dealers as we work to align our business with changing market conditions, and we are now turning our attention to creating momentum for a broader recovery.»

Honda Acura			BRAND REPORTS
Sales		COVID-19 Response Initiatives
Sales of Honda and Acura vehicles showed signs of improvement in the final weeks of April, with customer traffic increasing online and in dealer showrooms as state and local authorities eased restrictions on sales activities.		Honda has initiated a significant and comprehensive new effort to harness the spirit of community in responding to the impact of the COVID-19 pandemic. Specific initiatives include:

•	Honda and Acura dealers continue to focus on taking care of existing customers through vehicle service, maintenance and repair, while preserving the health and safety of their customers and employees.	•	Honda has teamed up with Dynaflo, Inc. to produce diaphragm compressors, a key component of portable ventilators that are used in hospitals and by first responders to help COVID-19 patients. The companies aim to produce 10,000 compressors per month once production reaches capacity.

•	A number of Honda and Acura dealers remained closed for much of April in compliance with mandates imposed on businesses by state and local authorities.	•	Honda associates have been using 3D printers to produce face shields at various company operations, with Honda engineers now working on a method to mass-produce face shield frames in Honda facilities.

•	Last month, Honda and Acura opened enrollment in new online retailing programs, Shop Simple with Honda and Acura Precision Purchase, and received a tremendous response from Honda and Acura dealers looking for an online retailing solution to meet the needs of our customers.	•	As the COVID-19 pandemic can add financial stress to the lives of our customers, Honda and Acura have offered to help customers who have financed their vehicle through Honda Financial Services or Acura Financial Services with payment extensions and deferrals, as well as available late fee waivers.

•	Honda is providing an industry-first special offer for first responders and medical professionals, out of respect for their contribution to communities across the country.	•	Honda has pledged $1.0 million to address food insecurity in communities across the U.S., Canada and Mexico, providing the most vulnerable with access to food.

		•	Additional projects and contributions are in the works, check Hondanews.com for updates.


	American Honda Vehicle Sales for April 2020
			Month-to-Date				Year-to-Date
			April 2020	April 2019	DSR** % Change	MoM % Change	April 2020	April 2019	DSR** % Change	YoY % Change
	American Honda Total		57,751	125,775	-55.8%	-54.1%	356,536	495,562	-28.8%	-28.1%
	Total Car Sales		25,610	57,452	-57.1%	-55.4%	157,455	226,535	-31.2%	-30.5%
	Total Truck Sales		32,141	68,323	-54.8%	-53.0%	199,081	269,027	-26.7%	-26.0%
	Honda	Total Car Sales	24,049	54,030	-57.2%	-55.5%	147,456	212,483	-31.3%	-30.6%
	Honda	Total Truck Sales	28,656	60,058	-54.1%	-52.3%	175,502	235,007	-26.1%	-25.3%
	Acura	Total Car Sales	1,561	3,422	-56.1%	-54.4%	9,999	14,052	-29.5%	-28.8%
	Acura	Total Truck Sales	3,485	8,265	-59.5%	-57.8%	23,579	34,020	-31.4%	-30.7%
	* Total Domestic Car Sales		22,290	46,949	-54.3%	-52.5%	138,123	183,071	-25.3%	-24.6%
		Honda Division	20,755	43,678	-54.3%	-52.5%	128,329	169,551	-25.1%	-24.3%
		Acura Division	1,535	3,271	-54.9%	-53.1%	9,794	13,520	-28.3%	-27.6%
	* Total Domestic Truck Sales		32,104	65,704	-53.0%	-51.1%	198,542	257,096	-23.5%	-22.8%
		Honda Division	28,619	57,439	-52.1%	-50.2%	174,963	223,076	-22.3%	-21.6%
		Acura Division	3,485	8,265	-59.5%	-57.8%	23,579	34,020	-31.4%	-30.7%
	Total Import Car Sales		3,320	10,503	-69.6%	-68.4%	19,332	43,464	-56.0%	-55.5%
		Honda Division	3,294	10,352	-69.4%	-68.2%	19,127	42,932	-55.9%	-55.4%
		Acura Division	26	151	-83.4%	-82.8%	205	532	-61.8%	-61.5%
	Total Import Truck Sales		37	2,619	-98.6%	-98.6%	539	11,931	-95.5%	-95.5%
		Honda Division	37	2,619	-98.6%	-98.6%	539	11,931	-95.5%	-95.5%
		Acura Division	0	0	0.0%	0.0%	0	0	0.0%	0.0%
MODEL BREAKOUT BY DIVISION
	Honda Division Total		52,705	114,088	-55.6%	-53.8%	322,958	447,490	-28.5%	-27.8%
		ACCORD	8,851	19,239	-55.8%	-54.0%	55,976	83,650	-33.7%	-33.1%
		CIVIC	13,410	28,436	-54.7%	-52.8%	77,354	106,621	-28.2%	-27.4%
		CLARITY	90	1,079	-92.0%	-91.7%	1,345	5,047	-73.6%	-73.4%
		CR-Z	0	1	-100.0%	-100.0%	1	2	-50.5%	-50.0%
		FIT	1,187	3,247	-64.8%	-63.4%	8,366	9,635	-14.0%	-13.2%
		INSIGHT	511	2,028	-75.8%	-74.8%	4,414	7,528	-41.9%	-41.4%

		CR-V	12,201	28,344	-58.6%	-57.0%	83,387	115,624	-28.6%	-27.9%
		HR-V	2,906	7,272	-61.6%	-60.0%	22,320	28,921	-23.6%	-22.8%
		ODYSSEY	3,933	7,482	-49.5%	-47.4%	20,323	28,779	-30.1%	-29.4%
		PASSPORT	1,594	2,907	-47.3%	-45.2%	9,427	7,721	20.9%	22.1%
		PILOT	6,562	11,399	-44.6%	-42.4%	30,460	44,356	-32.0%	-31.3%
		RIDGELINE	1,460	2,654	-47.1%	-45.0%	9,585	9,606	-1.2%	-0.2%

	Acura Division Total		5,046	11,687	-58.5%	-56.8%	33,578	48,072	-30.8%	-30.2%
		ILX	506	1,152	-57.8%	-56.1%	3,247	4,293	-25.1%	-24.4%
		NSX	5	23	-79.1%	-78.3%	39	102	-62.1%	-61.8%
		RLX / RL	26	151	-83.4%	-82.8%	205	532	-61.8%	-61.5%
		TLX	1,024	2,096	-53.0%	-51.1%	6,508	9,125	-29.4%	-28.7%

		MDX	1,725	3,339	-50.3%	-48.3%	10,666	14,122	-25.2%	-24.5%
		RDX	1,760	4,926	-65.6%	-64.3%	12,913	19,898	-35.7%	-35.1%

	Selling Days		26	25			102	101
	**** Electrified Vehicles		2,019	5,355	-63.7%	-62.3%	12,598	20,375	-38.8%	-38.2%

* Honda and Acura vehicles are made of domestic & global sourced parts

** Daily Selling Rate

**** Electrified Vehicles equal: Total sales of Hybrid (FHEV & PHEV), EVs (BEV) and Fuel Cell Vehicles (FCV) from the Honda and Acura brands.

PDF – https://mma.prnewswire.com/media/1163156/Honda_April_2020_Sales_Release.pdf

Logo – https://mma.prnewswire.com/media/477245/HONDALOGO_Logo.jpg

SOURCE American Honda Motor Co., Inc.

Alianza de Impacto Latino, the Ismael Cala Foundation, and the PAHO analyzed Covid-19 risks in Latin America

MIAMI, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — «Investing in public health systems must be ongoing and extend beyond the Covid-19 pandemic, because that is the only model that can guarantee quality access in every country.» This was one of the conclusions from the virtual event <a target="_blank"…

During the event, Ismael Cala, president of the Ismael Cala Foundation, interviewed Dr. Marcos Espinal, director of the Department of Communicable Diseases and Health Analysis of the Pan American Health Organization (PAHO), the Regional Office of the Americas of the World Health Organization (WHO).

They discussed the danger of the virus, but also the existence of other problems in the region, such as domestic violence and mental health, which pose a huge risk to the most vulnerable populations.

They also pointed out the risks of living in a globalized world that is heavily affected by the circulation of fake news, and they recommended preventing disinformation through exhaustive verification of sources.

According to data provided by Dr. Espinal, there are currently more than 180 medical studies on Covid-19 under way. However, no recommendations will be made until efficacy is proved.

Regarding a vaccine, there are currently four research trials under way on humans. A vaccine could be ready in October, but even if it is effective production and distribution to all countries will take time.

Finally, the Pan American Health Organization asked governments to be careful in lifting current social distancing measures to avoid a spike in cases.

Hospital capacity and support for those who remain in isolation should be guaranteed, especially in the poorest countries.

Dr. Marcos Espinal is currently the director of the Department of Communicable Diseases and Health Analysis of the Pan American Health Organization (PAHO), the Regional Office of the Americas of the World Health Organization (WHO). He has worked in matters linked to forgotten, tropical and vector-transmitted diseases, communication of risks and outbreaks, HIV, hepatitis, tuberculosis and STDs.

The Ismael Cala Foundation supports the development of emotional leadership and education of children, adolescents and young adults who are in vulnerable positions in Latin America, and of the Hispanic population in the USA. To achieve its mission, the Foundation has created several programs, including the Scholarship Program. Educational institutions, companies, and other organizations involved in social development have joined forces to promote the education and training of young people by channeling scholarships for courses and/or careers for personal and professional improvement, and thus improve their well-being and social progress.

La Alianza de Impacto Latino is an initiative that seeks to encourage the creation of partnerships for the sustainable growth and development of the Americas. It gathers together leaders from all sectors to support Sustainable Development of the Americas. It was created by the PVBLIC and Ismael Cala foundations.

The webinar can be seen on video here:

SOURCE Cala Enterprises Corporation

Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020

NEW YORK, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — The following is being issued by Prime Clerk, the court-appointed claims and noticing agent.

This is a reminder that Tuesday, June 30, 2020, at 5:00 p.m. (Prevailing Eastern Time) is the deadline or bar date for filing claims in the bankruptcy of Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. («Purdue«).

If someone thinks they have suffered harm from Purdue or its prescription opioids, such as OxyContin, they have the right to file a claim but will lose that right if they don’t file that claim by the bar date.

Filing a claim means you are seeking payment or other compensation from Purdue. Examples of claims that may be filed include claims alleging addiction, dependence, wrongful death, lost wages, loss of spousal relationship benefit for things such as child-rearing and enjoyment of life, or Neonatal Abstinence Syndrome (sometimes referred to as «NAS»).

Claims can be filed by you, your lawyer, a legal guardian, survivors, or relatives of people who have died or are disabled. You may file a claim even if you have received reimbursement from insurance.

Depending on the type of claim you file, you may be required to file a Personal Injury Claimant Proof of Claim Form and supporting documentation. Those claim forms and supporting documentation will be kept highly confidential and not made available to the public. You do not need an attorney to file a proof of claim for you.

Additionally, partnerships, corporations, joint ventures, trusts, governmental units, and Native American Tribes may also file a proof of claim against Purdue.

Go to www.PurduePharmaClaims.com to find Proof of Claim Forms and a complete list of instructions on how to file a claim. You will also find a list of the opioids produced, marketed or sold by Purdue. You can also request a claim form by mail, email or phone:

Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
850 Third Avenue, Ste. 412, Brooklyn, NY 11232
Email: purduepharmainfo@primeclerk.com
Phone: 1.844.217.0912

SOURCE Prime Clerk the Court-Appointed Claims and Noticing Agent

Mazda Reports April Sales Results

IRVINE, Calif., May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — Mazda North American Operations (MNAO) today reported total April sales of 10,940 vehicles, a decrease of 44.5 percent compared to April 2019. Year-to-date sales totaled 78,610 vehicles, a decrease of 13.2 percent. With 26 selling days in April, compared to 25 the year prior, the company posted a decrease of 46.6 percent on a Daily Selling Rate (DSR) basis.

CPO sales totaled 2,401 vehicles in April, a decrease of 53.8 percent compared to April 2019. Year-to-date CPO sales decreased 16.5 percent, with 19,052 vehicles sold.

Mazda Motor de Mexico (MMdM) reported April sales of 1,920 vehicles, a decrease of 55.3 percent compared to April last year. Year-to-date sales decreased 27.6 percent, with 14,842 vehicles sold.

Mazda North American Operations is headquartered in Irvine, California, and oversees the sales, marketing, parts and customer service support of Mazda vehicles in the United States and Mexico through approximately 620 dealers. Operations in Mexico are managed by Mazda Motor de Mexico in Mexico City. For more information on Mazda vehicles, including photography and B-roll, please visit the online Mazda media center at InsideMazda.MazdaUSA.com/Newsroom.

Follow MNAO’s social media channels through Twitter and Instagram at @MazdaUSA and Facebook at Facebook.com/MazdaUSA.


	Month-To-Date				Year-To-Date

	April	April	YOY %	% MTD	April	April	YOY %	% MTD
	2020	2019	Change	DSR	2020	2019	Change	DSR

Mazda3	1,492	4,351	(65.7)%	(67.0)%	9,610	19,566	(50.9)%	(51.4)%
Mazda6	746	2,340	(68.1)%	(69.3)%	5,252	9,261	(43.3)%	(43.8)%
MX-5 Miata	552	782	(29.4)%	(32.1)%	2,252	2,312	(2.6)%	(3.6)%
CX-3	363	1,019	(64.4)%	(65.7)%	2,915	4,272	(31.8)%	(32.4)%
CX-30	1,483	0			9,847	0
CX-5	5,220	9,592	(45.6)%	(47.7)%	40,431	47,088	(14.1)%	(15.0)%
CX-9	1,084	1,618	(33.0)%	(35.6)%	8,303	8,036	3.3%	2.3%


CARS	2,790	7,473	(62.7)%	(64.1)%	17,114	31,139	(45.0)%	(45.6)%
TRUCKS	8,150	12,229	(33.4)%	(35.9)%	61,496	59,396	3.5%	2.5%

TOTAL	10,940	19,702	(44.5)%	(46.6)%	78,610	90,535	(13.2)%	(14.0)%


*Selling Days	26	25			102	101

Logo – https://mma.prnewswire.com/media/53154/mazda_north_american_operations_logo.jpg

SOURCE Mazda North American Operations

HITEC Welcomes Google Cloud to the HITEC Familia

CHICAGO, May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — We are proud to announce Google Cloud has joined the HITEC community as a Gold-level Corporate Partner. This partnership highlights Google Cloud’s commitment to advancing diversity and to working collaboratively to develop the next generation of Hispanic technology leaders.

HITEC is the leading executive leadership organization for Hispanics in technology. HITEC’s vision is to connect, inspire, and grow influential Hispanic technology…

HITEC is the leading executive leadership organization for Hispanics in technology. HITEC’s vision is to connect, inspire, and grow influential Hispanic technology executives while developing the next generation of leaders.

«We’re honored to welcome Google Cloud to the HITEC Familia,» said Omar Duque, HITEC President. «We are excited to partner with an organization that has such an impactful footprint in the technology industry that will collaborate with us to share best practices and resources for talent growth and facilitate connections with the best and brightest Hispanic executives in technology.»

«Google Cloud is proud to partner with HITEC in our shared commitment to building and supporting teams that are representative of our global community,» said Carlos Granda, VP, Customer Success, Google Cloud and a 2019 HITEC 100 recipient. «I’m looking forward to Google Cloud and HITEC’s ongoing collaboration and I am excited to further support Hispanic executives and businesses through this partnership.»

About Google Cloud

Google Cloud provides organizations with leading infrastructure, platform capabilities and industry solutions. We deliver enterprise-grade cloud solutions that leverage Google’s cutting-edge technology to help companies operate more efficiently and adapt to changing needs, giving customers a foundation for the future. Customers in more than 150 countries turn to Google Cloud as their trusted partner to solve their most critical business problems.

About HITEC:

Founded to increase Hispanic representation in the diversity-challenged technology industry, HITEC is a premier global executive leadership organization of senior business and technology executives who have built outstanding careers in technology. HITEC’s premiere network spans the Americas and is focused on building stronger technology and executive leaders, leadership teams, corporations, and role models in a rapidly changing, flatter, and technology-centric world. These global leaders include executives leading Global 1000 corporations while others lead some of the largest Hispanic-owned technology firms across the Americas. HITEC enables business and professional growth for its members and fills the executive pipeline with the next generation of Hispanic technology leaders.

SOURCE Hispanic Information Technology Executive Council

Cancer Patients Face High Mortality from COVID-19

BRONX, N.Y., May 1, 2020 /PRNewswire-HISPANIC PR WIRE/ — People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine. The study, published today in the online edition of Cancer Discovery, is the largest so far to assess outcomes for patients with cancer who have also been infected with COVID-19.

«Our findings emphasize the need to prevent cancer patients from contracting COVID-19 and—if they do—to identify and closely monitor these individuals for dangerous symptoms,» said Vikas Mehta, M.D., M.P.H., a co-lead author of the study, a surgical oncologist at Montefiore and associate professor of otorhinolaryngology—head and neck surgery at Einstein. «We hope that our findings can inform states and communities that have not yet been so severely struck by this pandemic about the unique vulnerability cancer patients face.»

The study involved 218 cancer patients who tested positive for COVID-19 from March 18 to April 8, 2020 at Montefiore Medical Center in the Bronx, New York City, one of the regions in the United States hit hardest by the pandemic. A total of 61 cancer patients died from COVID-19, a dramatically high case-fatality rate of 28%. (The mortality rate for COVID-19 in the United States is 5.8%, according to the World Health Organization.)

«A key element is that mortality appears to be more closely related to frailty, age, and co-morbidities than to active therapy for cancer,» said co-senior author Balazs Halmos, M.D., M.S., director of the Multidisciplinary Thoracic Oncology Program at Montefiore and professor of medicine at Einstein.

«Our data suggest that we should not stop lifesaving cancer therapies, but rather develop strategies to minimize potential COVID-19 exposures and re-evaluate therapies for our most vulnerable cancer populations,» explained co-senior author Amit Verma, M.B.B.S., director of the division of hemato-oncology at Montefiore and professor of medicine and of developmental and molecular biology at Einstein.

The time period during which these patients were treated was earlier in the epidemic when testing was almost exclusively done in sicker, symptomatic patients who required hospitalization. This may partially explain the high fatality rate within the study’s cancer population. However, even when compared to mortality rates in non-cancer patients at Montefiore and across New York City during the same time period, cancer patients demonstrated a significantly higher risk of dying from COVID-19.

As a group, COVID-19 patients with hematologic (blood) cancers, such as leukemia and lymphoma, had the highest mortality rate: 37% (20 of 54 patients). For patients with solid malignancies, the mortality rate was 25% (41 of 164). Striking differences were observed among specific solid cancers: the mortality rate for patients with lung cancer was 55% and colorectal cancer was 38%, compared with mortality rates of 14% for breast cancer and 20% for prostate cancer.

Certain underlying conditions—older age, hypertension, heart disease, and chronic lung disease—were significantly associated with increased mortality among cancer patients with COVID-19.

A detailed analysis of patients with cancer who died from COVID-19 shows that more than half of these individuals—37 of 61—had been in places with a higher risk of exposure to COVID-19, such as nursing homes, hospitals or emergency departments within the 30 days before being diagnosed with COVID-19. This was before widespread social distancing had been implemented.

Montefiore has already changed clinical practice as a result of the study’s findings, by using telemedicine and early and aggressive social distancing for cancer patients, and by opening a dedicated cancer outpatient and inpatient clinical service. It has also instituted bilingual peer counseling and deployed social workers and food deliveries to its at-risk population.

Montefiore is able to quickly identify patients with a known history of cancer who test positive for COVID-19 based on a daily collection and collation of data across the health system. This allows the care team to act immediately to ensure appropriate care for these individuals and track outcomes.

The study’s other co-lead authors are Sanjay Goel, M.B.B.S., and Rafi Kabarriti, M.D. The paper is titled «Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.»

Additional Montefiore-Einstein authors are: Daniel Cole, M.D., Mendel Goldfinger, M.D., Ana Acuna-Villaorduna, M.D., Kith Pradhan, Ph.D., Raja Thota. M.S., Stan Reissman, M.S.W., Joseph A Sparano, M.D., Benjamin A. Gartrell, M.D., Richard V. Smith, M.D., Nitin Ohri, M.D., Madhur Garg, M.D., Andrew D. Racine, M.D., Ph.D., Shalom Kalnicki, M.D. and Roman Perez-Soler, M.D.

This study was supported in part by the Albert Einstein Cancer Center (P30CA013330).

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System; Albert Einstein College of Medicine

Prominent neurosurgeon Michael McDermott, M.D., joins Baptist Health South Florida to lead Miami Neuroscience Institute

CORAL GABLES, Florida, April 30, 2020 /PRNewswire-HISPANIC PR WIRE/ — Baptist Health South Florida welcomes Michael McDermott, M.D., a world-renowned leader in neurosciences with clinical expertise in the field of meningioma research and gamma knife radiosurgery, as its new chief medical executive of Miami Neuroscience Institute, formerly known as Baptist Health Neuroscience Center.

Dr. McDermott, widely known for advancing neurosurgical techniques,…

Dr. McDermott, widely known for advancing neurosurgical techniques, pioneered surgical management of meningioma, a slow-growing tumor in the head that affects the brain. He is an expert in the treatment of a wide variety of neurological disorders, in addition to meningiomas, skull base tumors, brain metastases, gliomas, hydrocephalus, central nervous system infections and complex tumors of the skull base and spinal cord.

«I am delighted to have a colleague of his caliber join our organization,» said Michael Zinner, M.D., chief executive officer and executive medical director at Miami Cancer Institute, part of Baptist Health South Florida. «His expertise will help enhance our collaborative and interdisciplinary approach to research and delivery of the best cancer treatments for our patients.»

Dr. McDermott has conducted leading research that generated more than 400 peer-reviewed publications and comes from the University of California San Francisco (UCSF) Medical Center, ranked by U.S. News & World Report as third in the nation in neurology and neurosurgery, where he was co-director of the Gamma Knife and CyberKnife Radiosurgery Program and held the distinguished Wolfe Family Endowed Professorship in Meningioma Research. In addition to serving as professor and vice chairman of neurological surgery, he is an accomplished educator. As residency program director, he trained young physicians from around the world.

«The arrival of Dr. McDermott to lead Miami Neuroscience Institute represents Baptist Health’s ability to harness the collective expertise of physician leaders and to offer the most innovative, comprehensive and individualized care available to our patients,» said Jack Ziffer, PhD, M.D., executive vice president, chief clinical officer and chief physician executive for Baptist Health South Florida.

Miami Neuroscience Institute provides care at all the Baptist Health facilities, with the exception of Boca Raton Regional Hospital, home to the renowned Marcus Neuroscience Institute, and Bethesda Hospital East and Bethesda Hospital West’s neuroscience programs. For the first several months, Dr. McDermott will focus on working with clinical and administrative leadership to plan and build the infrastructure as well as clinical depth and breadth of the program and set the stage for growth as a destination for neuroscience care.

«The multidisciplinary team approach we have at Baptist Health creates a special synergy between medical specialists from various fields to provide the most advanced care to our patients. This exceptional physician and surgeon will complement the tremendous medical talent that resides within Baptist Health and will continue to grow our national leadership in the treatment of conditions of the brain, spine and nervous system,» added Dr. Ziffer, PhD, M.D.

Miami Neuroscience Institute

Miami Neuroscience Institute, formerly known as Baptist Health Neuroscience Center, offers comprehensive and compassionate treatment for neurological conditions affecting the brain, spinal cord and peripheral nervous system. From non-surgical treatments and minimally invasive procedures to complex brain and spine surgery, the Center embraces a multidisciplinary approach to patient care.

Miami Neuroscience Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, nearly 23,000 employees, more than 4,000 physicians and more than 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.

SOURCE Baptist Health South Florida